Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M641Revenue (TTM) $M69.9Net Margin (%)15.6Altman Z-Score5.0
Enterprise Value $M540EPS (TTM) $0.2Operating Margin %15.0Piotroski F-Score6
P/E(ttm)57.1Beneish M-Score16.5Pre-tax Margin (%)15.3Higher ROA y-yY
Price/Book5.810-y EBITDA Growth Rate %--Quick Ratio7.7Cash flow > EarningsY
Price/Sales9.25-y EBITDA Growth Rate %--Current Ratio7.7Lower Leverage y-yY
Price/Free Cash Flow48.5y-y EBITDA Growth Rate %--ROA % (ttm)8.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)12.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M70.1ROIC % (ttm)86.3Gross Margin Increase y-yN

Gurus Latest Trades with PGNX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PGNXMario Gabelli 2016-09-30 Reduce$4.43 - $6.97
($6.05)
$ 9.1551%Reduce -32.00%17,000
PGNXKen Fisher 2016-09-30 Reduce$4.43 - $6.97
($6.05)
$ 9.1551%Reduce -23.30%107,663
PGNXJoel Greenblatt 2016-09-30 Buy $4.43 - $6.97
($6.05)
$ 9.1551%New holding48,873
PGNXMario Gabelli 2016-06-30 Buy $4.06 - $5.54
($4.82)
$ 9.1590%New holding25,000
PGNXKen Fisher 2016-06-30 Add$4.06 - $5.54
($4.82)
$ 9.1590%Add 0.12%140,361
PGNXKen Fisher 2015-12-31 Add$5.5 - $8.16
($6.57)
$ 9.1539%Add 68.40%140,191
PGNXKen Fisher 2015-09-30 Buy $5.48 - $9.42
($7.67)
$ 9.1519%New holding83,250
PGNXJulian Robertson 2015-06-30 Sold Out -1.29%$4.95 - $7.82
($6.05)
$ 9.1551%Sold Out0
PGNXJulian Robertson 2014-09-30 Buy 1.8%$4.15 - $5.56
($4.99)
$ 9.1583%New holding1,290,055
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PGNX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PGNX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ISRAEL ROBERT JExecutive Vice President, Medi 2015-06-11Sell2,000$6.8329.87view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-03-13Sell3,000$726.71view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-03-11Sell2,000$6.8329.87view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-03-03Sell5,000$6.4936.67view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-01-12Sell2,000$7.0625.64view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-12-11Sell3,000$7.0725.46view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-11-21Sell9,000$726.71view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-11-13Sell10,000$6.8329.87view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-11-11Sell5,000$6.5335.83view
Broadfin Healthcare Master Fun10% Owner 2014-07-21Buy1,625,436$4.692.83view

Quarterly/Annual Reports about PGNX:

News about PGNX:

Articles On GuruFocus.com
Tiger Management’s Julian Robertson Buys Alibaba, eBay, MasTec, Sells Tableau Software, Monsanto, Nov 14 2014 
Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street Nov 07 2014 
Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX Jan 27 2013 
Weekly CEO Buys Highlight: SUSP, ROVI, ZLC, MDW, PGNX Oct 01 2012 
5 Stocks That Dropped the Most Since Gurus Bought Them Sep 13 2012 
Dendreon Could Push Higher If New Drug Trials Succeed Apr 23 2012 
Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Dec 01 2010 
Progenics Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 08 2010 
Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Nov 02 2010 
Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Oct 04 2010 

More From Other Websites
Progenics Pharmaceuticals Announces First Patient Dosed in Phase 2/3 Clinical Trial of PSMA-Targeted... Dec 07 2016
Valeant (VRX) Ups Sales Force to Support Xifaxan/Relistor Nov 30 2016
ETFs with exposure to Progenics Pharmaceuticals, Inc. : November 23, 2016 Nov 23 2016
Progenics Pharmaceuticals, Inc. :PGNX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 21,... Nov 21 2016
PROGENICS PHARMACEUTICALS INC Financials Nov 16 2016
ETF’s with exposure to Progenics Pharmaceuticals, Inc. : November 11, 2016 Nov 11 2016
Progenics Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PGNX-US :... Nov 10 2016
Progenics Pharmaceuticals to Present at Upcoming Investor Conferences Nov 08 2016
Progenics Pharmaceuticals to Present at Upcoming Investor Conferences Nov 08 2016
PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Nov 07 2016
Progenics posts 3Q profit Nov 07 2016
Progenics posts 3Q profit Nov 07 2016
Progenics Pharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today Nov 07 2016
Progenics Pharmaceuticals Announces Third Quarter 2016 Financial Results and Business Update Nov 07 2016
Progenics Pharmaceuticals Announces Third Quarter 2016 Financial Results and Business Update Nov 07 2016
Progenics Announces $50 Million RELISTOR® Royalty-Backed Financing Nov 07 2016
Progenics Announces $50 Million RELISTOR® Royalty-Backed Financing Nov 07 2016
Portfolio Cuts Couldn’t Stop HealthInvest From Buying Up These Stocks Oct 29 2016
PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Other Events Oct 28 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)